Navigation Links
MBL Signs Non-Exclusive License With Envoy Therapeutics for Access to RIP-Chip Technology

WOBURN, Mass., March 15, 2011 /PRNewswire/ -- Medical & Biological Laboratories Co., Ltd., MBL, has signed a non-exclusive license with Envoy Therapeutics for access to MBL's patented RIP-Chip technology. As part of the license agreement, MBL will receive upfront payment, annual licensing fees and potential milestone payments. Envoy Therapeutics will utilize the RIP-Chip technology for the company's drug discovery and development.

MBL President Katsuhiko Nishida said, "We are pleased to enter into this agreement with Envoy, an innovative drug discovery company. This agreement provides Envoy a freedom-to-operate condition of our technology as well as a complementary approach to discover novel drug targets." President Nishida also lauded the scientific aspect of the agreement by stating, "RIP-Chip technology can provide additional information to their drug discovery pipelines regarding MOA and/or toxicological information of new drugs."  

RIP-Chip helps researchers understand the complex molecular networks involving genes, DNA, RNA, microRNA, proteins and RNA localization as mediated by specific binding proteins.  RIP-Chip technology is the only high-throughput approach for direct elucidation and analysis of these networks, whose importance has become increasingly clear with the growing appreciation for RNAi therapy, drug discovery and the role of RNA utilization in determining normal and disease outcomes.

About Medical & Biological Laboratories Co., Ltd.

Established in Nagoya, Japan, MBL was founded in 1969 as an antibody maker and is a leader in the development, manufacture, and distribution of antibodies and kits used in clinical diagnostics and life science research.  MBL Japan specializes in the business of diagnostic and research reagents as well as cytology products.  The MBL Network currently consists of 18 companies.  Additional information about MBL is available through its corporate website,

About Envoy Therapeutics

Envoy Therapeutics's mission is to discover new drugs with superior efficacy and fewer side effects than existing treatments. The company's bacTRAP® technology enables the identification of proteins in vivo that are produced by specific cell types without requiring the isolation of those cells. The technology is especially powerful in tissues of the brain, where many hundreds of cell types are intermingled. Additional information about Envoy Therapeutics is available through its corporate website,

SOURCE Medical & Biological Laboratories Co., Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
2. BioNeutral Signs Agreement With a Non-profit for Long-Term Removal of Formaldehyde to Save 10,000 Mobile Homes in Louisiana
3. Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
4. Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)
5. Martek Signs Multi-Year Sole-Source Supply Agreement With Hero
6. NicOx Signs Agreement With Capsugel for the Commercial Manufacture of Naproxcinod Oral Capsules
7. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
8. Huifeng Bio-Pharmaceutical (HFGB) Signs Exclusive Management Operating Agreement with Xian Qinba Xintong Medical Ltd.; HFGB to Retain Up to 70% of Qinbas Total Profit
9. Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards
10. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
11. StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists
Post Your Comments:
(Date:10/12/2015)... Oct. 12, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... engaged in developing and commercializing novel treatments in oncology, ... Dennis Turpin , the Company,s former Senior Vice ... its Quebec City office.  ... Chief Executive Officer of the Company commented, "After a ...
(Date:10/12/2015)... October 12, 2015 LabStyle Innovations ... Management Solution, today announced its Medical Director, Dr. ... at MobiHealth,s 5th EAI International Conference on Wireless ... through innovations in mobile and wireless technologies," the conference ... from October 14 - 16, 2015. The conference ...
(Date:10/12/2015)... , Oct. 12, 2015 VolitionRx Limited ... a completed clinical study of its NuQ ® blood-based ... the online issue of Clinical Epigenetics , the official ... conducted in collaboration with Lund University, ... Andersson , MD, PhD, Professor of Surgery and Vice-Dean, Faculty ...
(Date:10/12/2015)... Seattle WA (PRWEB) , ... October 12, 2015 , ... ... for the treatment of retinal diseases that can safely and chronically be administered as ... Global Health Impact Forum co-hosted by The Cleveland Clinic and taking place October 25th ...
Breaking Biology Technology:
(Date:10/6/2015)... , Oct. 6, 2015 Track Group, ... today that it has signed a contract with the ... across the full range of sentences under the Department,s ... of the Americas. "This contract with the Virginia DOC ... the US and advances our position as a trusted ...
(Date:10/5/2015)... ) releases ... (NASDAQ: NXTD ), a biometric authentication company focused ... ) releases the following market and ... a biometric authentication company focused on the growing mobile ... ) releases the following market and ...
(Date:10/1/2015)... Oct. 1, 2015  Biometrics includes diverse set ... body characteristics, such as fingerprints, eye retinas, facial ... of biometrics technology has been constantly increasing in ... five years. In addition to the most prominent ... recognition, other means of biometric authentication are rapidly ...
Breaking Biology News(10 mins):